FinTech
Noxopharm: Announces novel mRNA “vaccine enhancer” product
Noxopharm Announces novel mRNA “vaccine enhancer” productNoxopharm (NOX) is developing a new mRNA “vaccine enhancer” product to improve the effectiveness of vaccines and...
FinTech
Noxopharm: Appoints new CEO
Noxopharm Appoints new CEONoxopharm Limited (NOX) announces a shift in leadership in preparation for an upcoming ‘growth phase’
Dr Gisela Mautner has been...
FinTech
Noxopharm: Signs licensing agreement with Hudson Institute for RNA technology
Noxopharm Signs licensing agreement with Hudson Institute for RNA technologyNoxopharm (NOX) signs licensing agreement with Hudson Institute of Medical Research for its cutting-edge...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
